Man­u­fac­tur­ing roundup: Astel­las to sell Dutch fa­cil­i­ty to Del­pharm; Au­ri­gene in­vest­ing $40M in­to In­dia man­u­fac­tur­ing fa­cil­i­ty

Astel­las Phar­ma is sell­ing its man­u­fac­tur­ing plant in Mep­pel, the Nether­lands, to con­tract man­u­fac­tur­er Del­pharm.

Astel­las said last week it’s trans­fer­ring the fa­cil­i­ty to Del­pharm …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER